Medical Condition News

RSS

ReproCELL to begin commercialization of human iPS-derived neurons for Alzheimer's

ReproCELL, Inc. announces today that the company will start commercializing human iPS-derived neurons in which an Alzheimer's disease related gene has been incorporated.

8 Jun 2012

Study identifies molecular changes responsible for abnormal cholesterol production and metabolism

A new study from the Virginia Commonwealth University School of Medicine has identified molecular changes responsible for abnormal cholesterol production and metabolism in the livers of patients with a common liver condition, and these changes may explain the severity of a patient's liver disease and risks to their heart health.

8 Jun 2012

Longer looks: The impossible quest to find out the cost of care; Toobin's tips on SCOTUS decision

When the nurse calls my name, I head up to the check-in desk. "I'm sorry," she says as she lowers her eyes and hands me the phone. On the other end of the line, a woman identifies herself as a "third-party intermediary" for my insurance company. She says she is calling to inform me that the procedure I am scheduled to have in just a few minutes has been approved ... However, my chosen provider is more expensive than other options and may result in a higher co-payment. ... I ask the obvious question: "If I stay, how much will it cost me?" Her answer is that she is not authorized to give me that information.

8 Jun 2012

HRS, eCardio partner to raise awareness of heart rhythm disorders

eCardio Diagnostics, a leading provider of remote cardiac arrhythmia monitoring, was among eight corporate sponsors teaming up with the Heart Rhythm Society to raise the level of awareness for heart rhythm disorders, particularly Atrial Fibrillation (AF) and Sudden Cardiac Arrest.

8 Jun 2012

Branches following complex aortic aneurysm repair appear to be durable: Study

Branches following complex aortic aneurysm repair appear to be durable and are rarely the cause of patient death following complex aortic aneurysm repair according to a study presented at the 66th Vascular Annual Meeting presented by the Society for Vascular Surgery.

8 Jun 2012

Modulation Therapeutics receives MMRF grant for new multiple myeloma treatment

The Multiple Myeloma Research Foundation (MMRF) today announced that it has awarded $500,000 through its Biotech Investment Award (BIA) program to Modulation Therapeutics. Since the inception of this MMRF program in 2006, $11.5 million has been committed to 12 biotech companies in multi-year, results-driven funding for the development of innovative treatments for patients with multiple myeloma.

8 Jun 2012

NCI presents long-term outcomes from BiovaxID lymphoma vaccine Phase II trial at ASCO 2012

Biovest International, Inc., a majority-owned subsidiary of Accentia Biopharmaceuticals, Inc., today announced that the U.S. National Cancer Institute (NCI) presented long-term (median 10-year follow-up) outcomes at the 2012 American Society of Clinical Oncology Annual Meeting (ASCO 2012) from a Phase II BiovaxID lymphoma vaccine clinical trial.

8 Jun 2012

Scientists create cancer model built in the fruit fly Drosophila

Researchers from Mount Sinai School of Medicine developed a cancer model built in the fruit fly Drosophila, then used it to create a whole new approach to the discovery of cancer treatments. The result is an investigational compound AD80 that precisely targets multiple cancer genes.

8 Jun 2012

Researchers identify brain receptor that appears to play a central role in regulating appetite

Researchers at Columbia University Medical Center (CUMC) have identified a brain receptor that appears to play a central role in regulating appetite. The findings, published today in the online edition of Cell, could lead to new drugs for preventing or treating obesity.

8 Jun 2012

Millions of pre-diabetic Americans may be at increased risk of future stroke

Millions of pre-diabetic Americans may be at increased risk of future stroke, say researchers at the University of California, San Diego School of Medicine in a new meta-analysis of epidemiological studies, but the precise degree of that threat is confounded by differing medical definitions and factors that remain unknown or unmeasured.

8 Jun 2012

Roche files TnT-hs assay 510(k) submission with FDA for use on laboratory analyzers

Roche announced today that it has filed a 510(k) submission to the U.S. Food and Drug Administration (FDA) for a fully automated TnT-hs assay for use on Roche's full portfolio of laboratory analyzers.

From Roche Sequencing and Life Science 8 Jun 2012

Scientists discover new function for thrombospondin protein

Scientists have discovered a new function for a protein that protects cells during injury and could eventually translate into treatment for conditions ranging from cardiovascular disease to Alzheimer's.

8 Jun 2012

Ocular pulse amplitude reliable, safe screening test for carotid artery stenosis

A simple eye test may someday offer an effective way to identify patients who are at high risk for stroke, say researchers at the University of Zurich. They showed that a test called ocular pulse amplitude (OPA) can reliably detect carotid artery stenosis (CAS), a condition that clogs or blocks the arteries that feed the front part of the brain.

8 Jun 2012

MGH, HSG to conduct PBT2 clinical trial in Huntington's disease

The Huntington Study Group (HSG), under the leadership of Ray Dorsey, M.D. with Johns Hopkins Medical and Diana Rosas, M.D. with Massachusetts General Hospital, is conducting a clinical trial in Huntington's disease (HD) throughout the United States and Australia, "A randomized, double-blind, placebo-controlled, study to assess the safety and tolerability, and efficacy of PBT2 in patients with early to mid-stage Huntington's disease" comparing a 100 mg dose or 250 mg dose versus placebo.

8 Jun 2012

Food allergies more prevalent among urban children

Children living in urban centers have a much higher prevalence of food allergies than those living in rural areas, according to a new study, which is the first to map children's food allergies by geographical location in the United States. In particular, kids in big cities are more than twice as likely to have peanut and shellfish allergies compared to rural communities.

8 Jun 2012

Anti-TNFs increase risk of shingles in patients with inflammatory rheumatic diseases

Patients with inflammatory rheumatic diseases (IRD) treated with anti-tumour necrosis factor medications (anti-TNFs) have a 75% greater risk of developing herpes zoster, or shingles, than patients treated with traditional disease modifying anti-rheumatic drugs (DMARDs), according to a meta-analysis presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism.

8 Jun 2012

Successful pregnancies common for female liver transplant recipients

New research confirms that successful pregnancies are common for female liver transplant recipients. The study appearing in the June issue of Liver Transplantation, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, found miscarriage risk was lower and the live birth rate higher among women following liver transplantation than in the general U.S. population.

7 Jun 2012

BRF to fund research that focuses on sports-related concussive injuries among young children

The Brain Research Foundation (BRF) today announced it will fund research that aims to improve pediatricians' ability to evaluate and manage sports-related concussive injuries among young children, and guide future research regarding the diagnosis, treatment and long term effects of these events.

7 Jun 2012

CardioKinetix commences Parachute Ventricular Partitioning Device clinical trial in IHF

CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, announced today that it has begun enrollment in PARACHUTE III, a post-market safety surveillance trial, in Germany with the CE Marked Parachute Ventricular Partitioning Device.

7 Jun 2012

Novartis, Foundation Medicine announce new agreement to offer genomic analysis

Foundation Medicine today announced a new agreement with Novartis to provide comprehensive genomic analysis in support of Novartis' clinical oncology programs.

7 Jun 2012

Medical Condition News

ReproCELL to begin commercialization of human iPS-derived neurons for Alzheimer's

Study identifies molecular changes responsible for abnormal cholesterol production and metabolism

Longer looks: The impossible quest to find out the cost of care; Toobin's tips on SCOTUS decision

HRS, eCardio partner to raise awareness of heart rhythm disorders

Branches following complex aortic aneurysm repair appear to be durable: Study

Modulation Therapeutics receives MMRF grant for new multiple myeloma treatment

NCI presents long-term outcomes from BiovaxID lymphoma vaccine Phase II trial at ASCO 2012

Scientists create cancer model built in the fruit fly Drosophila

Researchers identify brain receptor that appears to play a central role in regulating appetite

Millions of pre-diabetic Americans may be at increased risk of future stroke

Roche files TnT-hs assay 510(k) submission with FDA for use on laboratory analyzers

Scientists discover new function for thrombospondin protein

Ocular pulse amplitude reliable, safe screening test for carotid artery stenosis

MGH, HSG to conduct PBT2 clinical trial in Huntington's disease

Food allergies more prevalent among urban children

Anti-TNFs increase risk of shingles in patients with inflammatory rheumatic diseases

Successful pregnancies common for female liver transplant recipients

BRF to fund research that focuses on sports-related concussive injuries among young children

CardioKinetix commences Parachute Ventricular Partitioning Device clinical trial in IHF

Novartis, Foundation Medicine announce new agreement to offer genomic analysis

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News